Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

The discovery of microbial-sensing proteins called Toll-like receptors is transforming our ... Vaccines for diseases such as AIDS, hepatitis C, malaria, and even cancer might be made more ...

Further, the two samples that they missed were acute-phase sera, and subsequent samples from these same patients proved to be positive for what Chiron now called the hepatitis C virus. Michael ...

Toll-like receptors (TLRs ... showed promising results for the treatment of viral infections, such as HIV, influenza, HBV and HCV. Efforts to develop TLR antagonists for the treatment of virus ...

virus receptors and virus assembly. Is studying several viruses from the simple picornaviruses through the more complex flaviviruses and togaviruses. These include human pathogens such as yellow fever ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular carcinoma (HCC) development.

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Hepatitis B and C still survive in the dark, driven by a lack of information, unhygienic medical procedures, and poor access ...